Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
Crossref DOI link: https://doi.org/10.1186/s12885-015-1444-1
Published Online: 2015-07-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Butrym, Aleksandra
Lech-Maranda, Ewa
Patkowska, Elżbieta
Kumiega, Beata
Bieniaszewska, Maria
Mital, Andrzej
Madry, Krzysztof
Torosian, Tigran
Wichary, Ryszard
Rybka, Justyna
Warzocha, Krzysztof
Mazur, Grzegorz
License valid from 2015-07-08